Effects of Exenatide vs. Insulin Aspart on Glycemic Control and Hypoglycemia in Diabetes Patients Treated with Metformin: Primary Results of a Randomized, Open-Label Study

被引：0
|
作者：
Gallwitz, Baptist
Boehmer, Michael
Segiet, Thomas
Moelle, Andrea
Milek, Karsten
Becker, Bernd
Helsberg, Karin
Petto, Helmut
Peters, Natalie
Bachmann, Oliver
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [1] Excnatide vs. insulin aspart in patients with type 2 diabetes: results of a randomised, open-label study
    Gallwitz, B.
    Boehmer, M.
    Segiet, T.
    Moelle, A.
    Milek, K.
    Becker, B.
    Helsberg, K.
    Petto, H.
    Peters, N.
    Bachmann, O.
    DIABETOLOGIA, 2010, 53
  • [2] Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes A randomized 26-week study on glycemic control and hypoglycemia
    Gallwitz, Baptist
    Bohmer, Michael
    Segiet, Thomas
    Molle, Andrea
    Milek, Karsten
    Becker, Bernd
    Helsberg, Karin
    Petto, Helmut
    Peters, Natalie
    Bachmann, Oliver
    DIABETES CARE, 2011, 34 (03) : 604 - 606
  • [3] The Relationship of Recurrent Hypoglycemia with Glycemic Control and Insulin Change in Patients Treated with Insulin Glargine and Exenatide Twice Daily vs. Insulin Lispro or Placebo
    Strand, Jorma
    Gouet, Didier
    Han, Jenny
    Ruggles, James
    Zhuplatov, Sergey
    DIABETES, 2015, 64 : A645 - A645
  • [4] Treatment efficacy and glucose variability control of exenatide versus biphasic insulin aspart 30 in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicenter, randomized, open-label, parallel study
    Liu, Xiangyang
    Ji, Qiuhe
    Yang, Wenjuan
    Liu, Jianrong
    Gao, Xiling
    He, Qingzhen
    Ma, Kaiyan
    Tian, Zhufang
    Xie, Xuan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [5] Combination of Linagliptin and Metformin Improves Glycemic Control in Type 2 Diabetes: A Randomized Trial with an Open-Label Arm in Patients with Poor Glycemic Control
    Haak, Thomas
    Meinicke, Thomas
    Jones, Russell
    Von Eynatten, Maximilian
    Woerle, Hans J.
    DIABETES, 2011, 60 : A77 - A77
  • [6] Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study
    Sun, Rui
    Yuan, Lu
    Shen, Yun
    Shen, Ziyang
    Ding, Bo
    Ma, Jianhua
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2911 - 2919
  • [7] Exenatide maintains glycemic control for 2 years in patients with type 2 diabetes: data from an ongoing, open-label study
    Ratner, RE
    Stonehouse, A
    Gao, HY
    Poon, T
    Kim, D
    DIABETOLOGIA, 2005, 48 : A288 - A289
  • [8] Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial
    Zhang, Xiuzhen
    Xu, Dan
    Xu, Ping
    Yang, Shufen
    Zhang, Qingmei
    Wu, Yan
    Yuan, Fengyi
    ENDOCRINE CONNECTIONS, 2021, 10 (09) : 1045 - 1054
  • [9] Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
    Aaron S Kelly
    Richard M Bergenstal
    J Michael Gonzalez-Campoy
    Harold Katz
    Alan J Bank
    Cardiovascular Diabetology, 11
  • [10] Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
    Kelly, Aaron S.
    Bergenstal, Richard M.
    Gonzalez-Campoy, J. Michael
    Katz, Harold
    Bank, Alan J.
    CARDIOVASCULAR DIABETOLOGY, 2012, 11
12345